Connect with us

International

United Kingdom: CIC responds to King Charles III's speech and says cannabis could grow the economy by billions of pounds

Published

em

Listen to this article
Photo: DR

The co-presidents of the Cannabis Industry Council (CIC), Jamie Bartley and Callie Seaman, responded to speech of King Charles III following the announcement of the government's legislative agenda. In the speech, it was mentioned that economic growth is a top priority for the United Kingdom, but there was no reference to cannabis to improve the country's situation.

The CIC responded, and in a statement assured the government and the King that cannabis has the potential to create jobs and grow the UK economy by billions of pounds, without public charges for the government.

Dr. Callie Seaman, CIC co-president. Photo: DR | The Frank Magazine

“The government has said that economic growth is a top priority during its term. Cannabis has the potential to grow the UK economy by billions of pounds and create jobs, without the government spending any public money. However, the King's speech bills do not address this reality”, says the CIC.

Furthermore, news emerged this week that a number of British cannabis companies are considering IPOs in New York, which the CIC says represents “a sign of regulatory failure to promote British economic interests.” ”. The CIC states that it will continue to pressure entities and the government to adopt “reforms that reduce bureaucracy and liberalize the markets for prescription cannabis, consumer CBD and industrial hemp”.

CIC publishes Manifesto for Change

Last June, the CIC published a 'manifesto' on cannabis for change in the cannabis space, with a series of policy proposals for the Government, which aim to improve patient access to medicines, increase foreign direct investment in the industry and increase farmers' income. The specific policies proposed by the manifesto were as follows:

  • A clear pathway for patients to access private prescriptions from unlicensed CBPMs at NHS appointments;
  • Increased reimbursement of private prescriptions for cannabis-based medicines for certain indications by the NHS and insurers;
  • Home Office that allows the electronic prescription of cannabis-based medicines, both from a legal and technical point of view (NHS Digital)
  • Review of the Proceeds of Crime Act to allow legitimate foreign investment in the cannabis industry;
  • Home Office allowing the extraction of CBD flowers with an industrial hemp license
  • The Government must establish a new body that brings together the various regulatory responsibilities for cannabis.

CIC co-presidents Jamie Bartley and Callie Seaman. Photo: DR

At the time, CIC co-president Callie Seaman stated that “the cannabis industry has the potential to make substantial contributions to health, the environment and the economy. However, the industry is currently being stifled by unnecessary bureaucracy, unclear pathways for patients to access affordable prices, and arbitrary restrictions on capital investment. The Cannabis Industry Council is pushing politicians and lawmakers to make these uncontroversial but transformative changes to help patients and doctors.”

The government had shortly before announced positive changes to hemp licensing practices, including increasing permitted levels of THC in hemp crops to at least 0,3%. The Advisory Council on the Misuse of Drugs (ACMD) has committed to providing advice on the THC limit by October 2024.

CIC Co-Chair Jamie Bartley commented: “Rising temperatures in the UK could trigger a natural rise in THC levels in the hemp plant, pushing it above the threshold. This poses a risk to farmers, who may have to destroy any non-compliant crops. Increasing the THC limit would be a crucial vote of confidence in the agricultural sector, which has been hit by reduced subsidies and increased competition from countries with lower standards”, he warned.

 

____________________________________________________________________________________________________

[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages ​​using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]

____________________________________________________________________________________________________

What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!

+ posts

With a degree in Journalism from the University of Coimbra, Laura Ramos has a postgraduate degree in Photography and has been a Journalist since 1998. She was a correspondent for Jornal de Notícias in Rome, Italy, and Press Advisor at the Office of the Minister of Education. She has an international certification in Permaculture (PDC) and created the street-art photographic archive “What says Lisbon?” @saywhatlisbon. Laura is currently Editor of CannaReporter and CannaZine, as well as founder and program director of PTMC - Portugal Medical Cannabis. She directed the documentary “Pacientes” and was part of the steering group of the first Postgraduate in GxP's for Medicinal Cannabis in Portugal, in partnership with the Military Laboratory and the Faculty of Pharmacy of the University of Lisbon.

Click here to comment
Subscribe
Notify of

0 Comments
Inline feedback
View all comments
Advertising


Watch the Documentary "Patients"

Documentary Patients Laura Ramos help us grow

Mais recentes

International5 days ago

Volkswagen invests in industrial hemp leather for car interiors

After brands such as Ford, BMW or Mercedes, Volkswagen has started a cooperation with the German start-up Revoltech GmbH...

International5 days ago

Jazz Pharmaceuticals fails Phase 3 Epidyolex clinical trial in Japan

Pharmaceutical giant Jazz recently announced that its leading cannabinoid treatment, Epidyolex, failed clinical trials...

Press Releases6 days ago

UK: Landlords risk breaching Equality Act over prescribed cannabis

Landlords, property managers and housing associations are currently at risk of breaching the Equality Act due to...

International6 days ago

USA: New York destroys four tons of cannabis products worth $63 million

City officials in New York City have incinerated more than four tons of unregulated cannabis products...

Events7 days ago

Product Earth kicks off in London next weekend

The 9th edition of Product Earth will take place on the 7th and 8th of September, at Drumsheds, in London, United Kingdom...

International7 days ago

USA – Legalization did not increase cannabis use, but reduced alcohol consumption and surpassed it

Young Americans are using less cannabis today than in 2014, but for the first time since...

Press Releases7 days ago

VertiFarm will showcase the latest technological trends and innovations for cannabis production

International trade fair to provide information on efficient cultivation options for useful, nutritious and health-promoting cannabis products and applications...

Press Releases2 weeks ago

Cannabis Industry Council, Medical Cannabis Clinicians Society and Drug Science Announce Cannabis Industry Awards

The inaugural Cannabis Industry Awards Dinner was announced by the Cannabis Industry Council, Medical Cannabis...

Press Releases2 weeks ago

Cosma SA and SOMAÍ Pharmaceuticals partner to revolutionize Poland with the most innovative cannabis-based solutions

Cosma SA, a leader in cannabis-based pharmaceutical advancements, and SOMAÍ Pharmaceuticals, a fully integrated Multinational Operator (MCO)...

Press Releases2 weeks ago

Biotech Overseed raises €6,7 million to become France’s first manufacturer of 100% medicinal cannabis products

In a field recognized as a priority public health issue, Overseed becomes a major pharmaceutical player and plays a...